Projects
The pharmaceutical projects listed in this section are those that are announced from time to time around the world
Wilmington PharmaTech Invests $50 Million to Double U.S. API Manufacturing Capacity
Wilmington PharmaTech, a USbased contract research, development, and manufacturing organisation CRDMO, has announced a $50 million expansion of its Delaware campus The project aims
ESTEVE CDMO Invests $15.5 Million to Expand Chicago Small Molecule API Facility
ESTEVE CDMO has launched a $155 million expansion of its North American facility in Morton Grove, Illinois
Novo Nordisk Invests €432 Million to Expand Athlone Manufacturing Facility
Novo Nordisk has announced an investment of 432 million to expand its tabletting facility in Ireland
Axplora Invests €30 Million to Boost Lyophilization Capacity at Le Mans Facility
Axplora, a contract development and manufacturing organisation CDMO specialising in complex small molecules and antibodydrug conjugates ADCs, has announced a major investment to expand its lyophilization freezedrying
Novartis Strengthens US Operations with $23B Radioligand Therapy Expansion
Novartis has announced plans to build a 46,000squarefoot radioligand therapy RLT manufacturing site in Denton This will be the companys fifth RLT site in the United States and its first manufacturing facility in Texas
FUJIFILM Invests £400M to Expand Biomanufacturing and Process Development Capacity
FUJIFILM Biotechnologies, a global contract development and manufacturing organisation CDMO for biologics, vaccines, and advanced therapies, has expanded its site in Teesside, UK, with a total investment
Lilly Announces New $3.5B Injectable Manufacturing Facility in Pennsylvania
Eli Lilly and Company has announced plans to invest more than $35 billion in a new injectable medicine and device manufacturing facility in the Lehigh Valley, Pennsylvania The site will support the production
Novartis Strengthens Radioligand Therapy Supply in U.S. with $23B Investment
Novartis has announced plans to construct its fourth radioligand therapy RLT manufacturing facility in Winter Park, Florida This purposebuilt, 35,000squarefoot facility is part of the companys $23 billion US investment programme
Genentech Expands Holly Springs Operations with $2B Investment
Genentech has more than doubled its investment in a new biomanufacturing facility in Holly Springs, North Carolina, bringing the total commitment to around $2 billion The expansion forms part of Roche and Genentechs $50 billion investment
Sharp Sterile Manufacturing Announces $28M Investment to Expand Lee Facility
Sharp Sterile Manufacturing has announced a $28 million expansion of its Lee, Massachusetts site, aiming to increase production capacity and support local skilled jobs in the life sciences sector
